YU70703A - Priprema flastera koji sadrže induktor hipersenzitiviteta sa odloženim dejstvom i metode za njegovo korišćenje - Google Patents

Priprema flastera koji sadrže induktor hipersenzitiviteta sa odloženim dejstvom i metode za njegovo korišćenje

Info

Publication number
YU70703A
YU70703A YU70703A YUP70703A YU70703A YU 70703 A YU70703 A YU 70703A YU 70703 A YU70703 A YU 70703A YU P70703 A YUP70703 A YU P70703A YU 70703 A YU70703 A YU 70703A
Authority
YU
Yugoslavia
Prior art keywords
delayed
type hypersensitivity
topical patch
subject
hypersensitivity inducer
Prior art date
Application number
YU70703A
Other languages
English (en)
Inventor
Jutaro Shudo
Ichiro Mori
Original Assignee
Teikoku Pharma Usa Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Pharma Usa Inc. filed Critical Teikoku Pharma Usa Inc.
Publication of YU70703A publication Critical patent/YU70703A/sh
Publication of RS50729B publication Critical patent/RS50729B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A61F2013/0296—Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Opisan je preparat flastera koji sadrzi induktor hipersenziviteta sa odlozenim dejstvom. napr., I-dihloro-2,4-dinitrobenzen (DNCB), i metode za njegovo koriscenje. Preparati ovog flastera su nacinjeni od preparata adhezivnog gela koji se nalazi na nosacu, pri cemu preparat adhezivnog gela sadrzi induktor hipersenziviteta sa odlozenim dejstvom, polimerni gel koji je rastvorijiv u vodi, vodu i agens za zadrzavanje vode. Pri koriscenju ovog preparata flastera, flaster se stavi na kozu subjekta i drzi na mestu primene period vremena koji je dovoljan da induktor hipersenziviteta sa odlozenim dejstvom deluje na subjekat, pri cemu ovo vreme u opstem slucaju nije duze od oko 60 minuta. Invencija subjekta ce naci primenu u razlicitim slucajevima kada je pozeljno dejstvo induktora hipersenziviteta sa odlozenim dejstvom, a narocito je pogodno za koriscenje u lecenju bolesnih stanja povezanih sa HIV-om, na pr., AIDS-a.
YUP-707/03A 2001-03-12 2002-02-22 Preparat flastera induktora hipersenzitiviteta sa odloženim dejstvom i njegova primena RS50729B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27521301P 2001-03-12 2001-03-12

Publications (2)

Publication Number Publication Date
YU70703A true YU70703A (sh) 2006-05-25
RS50729B RS50729B (sr) 2010-08-31

Family

ID=23051331

Country Status (22)

Country Link
US (3) US6761900B2 (sh)
EP (1) EP1370251A1 (sh)
JP (2) JP2004524327A (sh)
KR (2) KR20090117839A (sh)
CN (1) CN100594893C (sh)
AU (1) AU2002247209C1 (sh)
BR (1) BR0208005A (sh)
CA (1) CA2440209A1 (sh)
CR (1) CR7078A (sh)
EA (1) EA006208B1 (sh)
HK (1) HK1072364A1 (sh)
IL (2) IL157795A0 (sh)
ME (1) MEP9808A (sh)
MX (1) MXPA03008206A (sh)
NO (1) NO20033985L (sh)
NZ (1) NZ528098A (sh)
PL (1) PL363839A1 (sh)
RS (1) RS50729B (sh)
TW (1) TWI331521B (sh)
UA (1) UA79587C2 (sh)
WO (1) WO2002072081A1 (sh)
ZA (1) ZA200306997B (sh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6761900B2 (en) * 2001-03-12 2004-07-13 Teikoku Pharma Usa, Inc. Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
US20030118632A1 (en) * 2001-12-26 2003-06-26 Larry Caldwell Methods and compositions for treating carpal tunnel syndrome
US7645916B2 (en) * 2003-01-23 2010-01-12 Specialty Silicone Fabricators, Inc. Elastically deformable fabric with gel coated surface
US20040147187A1 (en) * 2003-01-23 2004-07-29 Rasor Allen C. Elastically deformable fabric with gel coated surface
ITMI20030414A1 (it) * 2003-03-06 2004-09-07 Biofarm S R L Ora Biofarmitalia S P A Tampone con strato di gel con attivita' cosmetica o terapeutica.
US20060211766A1 (en) * 2004-09-30 2006-09-21 Kaplan Leonard L Gelled immunomodulating topical compositions and a method of treating warts and other human papilloma virus skin infections
US8080261B2 (en) * 2004-09-30 2011-12-20 Teikoku Pharma Usa, Inc. 1-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same
AP2007003963A0 (en) * 2004-09-30 2007-04-30 Teikoku Pharma Usa Inc 1-Chloro-2,4-dinitrobenzene gel compositions and methods for using the same
AU2005323206C1 (en) * 2005-01-04 2010-01-07 Teikoku Pharma Usa, Inc. Cooling topical patch preparation
EP1940377A4 (en) * 2005-10-24 2010-12-08 Teikoku Pharma Usa Inc TOPICAL AEROSPECTIVE COMPOSITIONS OF N, 2,3-TRIMETHYL-2-ISOPROPYLBUTAMIDE AND METHOD OF USE THEREOF
JP5010829B2 (ja) * 2005-12-28 2012-08-29 帝國製薬株式会社 貼付剤
JP5010834B2 (ja) * 2006-02-20 2012-08-29 帝國製薬株式会社 貼付剤
KR101352238B1 (ko) 2007-04-04 2014-01-15 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 단순포진바이러스 감염 치료를 위한 비특이적 지연형 과민증 반응
WO2009005814A2 (en) * 2007-07-03 2009-01-08 Marchitto Kevin S Drug-delivery patch comprising a dissolvable layer and uses thereof
EP3494790A1 (en) 2010-03-02 2019-06-12 Phio Pharmaceuticals Corp. Effective sensitizing dose of a gelled immunomodulating topical composition
EP3087985B1 (en) * 2013-12-18 2018-10-17 Maruishi Pharmaceutical Co., Ltd. Hydrous adhesive patch
US20160279083A1 (en) * 2015-02-24 2016-09-29 Moein Health, Inc. Topical treatment for cervical intraepithelial neoplasia
US10588564B2 (en) 2014-09-30 2020-03-17 Moein Health, LLC Method and kit for diagnosing and treating neoplastic tissue
EP3261654B1 (en) 2015-02-26 2021-08-11 Squarex, LLC Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
KR101646181B1 (ko) 2015-08-18 2016-08-05 한양대학교 에리카산학협력단 이리노테칸 함유 이중역상 온도감응성 수용성 겔 조성물
US10371610B2 (en) 2016-02-23 2019-08-06 Noul Co., Ltd. Contact-type patch, staining method using the same, and manufacturing method thereof
KR20170099737A (ko) 2016-02-23 2017-09-01 노을 주식회사 접촉식 염색 패치 및 이를 이용하는 염색 방법
BR112021011103A8 (pt) * 2018-12-18 2022-08-09 Currahee Holding Company Inc Emplastro personalizado para aplicação tópica
CN112315661A (zh) * 2020-10-26 2021-02-05 广东泰宝医疗科技股份有限公司 一种持效期长的离子感应贴

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2375861A1 (fr) 1976-12-31 1978-07-28 Merieux Inst Tampon adhesif pour tests epicutanes
US4129547A (en) * 1977-06-30 1978-12-12 E. I. Du Pont De Nemours And Company High solids coating compositions for flexible substrates containing urea-formaldehyde
US4129647A (en) 1977-10-17 1978-12-12 Edmund Klein Treatment of acne
US4897260A (en) * 1987-05-22 1990-01-30 The Rockefeller University Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same
US5476664A (en) * 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
DE69524614T2 (de) * 1994-10-05 2002-09-12 Hisamitsu Pharmaceutical Co Arzneimittelbestandteile einschliesslich eines n-substituierten o-toluidinderivats und transdermal absorbierbare zubereitung
AU5543196A (en) * 1995-04-12 1996-10-30 Robert B. Hopp Skin patch for use in contact immunotherapy
JPH11171768A (ja) 1997-10-15 1999-06-29 Taisho Pharmaceut Co Ltd 消炎鎮痛外用剤
WO2001047559A1 (fr) 1999-12-27 2001-07-05 Teikoku Seiyaku Co., Ltd Pastilles a usage externe
US6761900B2 (en) * 2001-03-12 2004-07-13 Teikoku Pharma Usa, Inc. Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same

Also Published As

Publication number Publication date
NZ528098A (en) 2004-04-30
KR20030088457A (ko) 2003-11-19
UA79587C2 (en) 2007-07-10
JP2004524327A (ja) 2004-08-12
RS50729B (sr) 2010-08-31
JP2010013474A (ja) 2010-01-21
MXPA03008206A (es) 2004-11-12
CN100594893C (zh) 2010-03-24
US20040219200A1 (en) 2004-11-04
IL157795A0 (en) 2004-03-28
TWI331521B (en) 2010-10-11
MEP9808A (en) 2010-06-10
CR7078A (es) 2004-03-10
EA200300995A1 (ru) 2004-02-26
KR20090117839A (ko) 2009-11-12
CN1561202A (zh) 2005-01-05
WO2002072081A1 (en) 2002-09-19
HK1072364A1 (en) 2005-08-26
EP1370251A1 (en) 2003-12-17
BR0208005A (pt) 2004-03-02
NO20033985D0 (no) 2003-09-09
CA2440209A1 (en) 2002-09-19
IL157795A (en) 2007-08-19
AU2002247209B2 (en) 2005-11-17
ZA200306997B (en) 2004-09-08
PL363839A1 (en) 2004-11-29
US6761900B2 (en) 2004-07-13
NO20033985L (no) 2003-11-03
US20040219199A1 (en) 2004-11-04
US20020176886A1 (en) 2002-11-28
EA006208B1 (ru) 2005-10-27
AU2002247209C1 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
YU70703A (sh) Priprema flastera koji sadrže induktor hipersenzitiviteta sa odloženim dejstvom i metode za njegovo korišćenje
HK1108350A1 (en) Cooling topical patch preparation
JP2004524327A5 (sh)
GEP20032976B (en) Artificial Peptides Having Surface Activity and Use Thereof in The Preparation of Artificial Surfactant
ATE314092T1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
DK1079806T3 (da) Præparater til påföringen af antiinflammatoriske, især antiseptiske midler og/eller midler, der fremmer helingen af sår, til de övre luftveje og/eller öret
BR9715022A (pt) Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada
CY1105634T1 (el) Η χρηση του ραδιου -223 για τη στοχευση ασβεστωμενων ιστων για την ανακουφιση πονου και τη θεραπεια οστικου καρκινου
BR9911076A (pt) Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
MEP25008A (en) Topical methadone compositions and methods for using the same
NO20001042D0 (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
EP1428821A8 (en) Piperidin-4-yl amines with analgesic effect
HUP9801167A2 (hu) Triaromás vegyületek, azokat tartalmazó kompozíciók és alkalmazásuk
DE69613840D1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
FR2792500B1 (fr) Composition aqueuse, notamment sous forme de gel, a base de ho2f , acides et ions metalliques, procede de preparation notamment quand lesdits ions sont ag2+ et utilisation dans le domaine de la desinfection et/ou du traitement de surface
BR0317888A (pt) Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
HUP0400548A2 (hu) Belső szemnyomást csökkentő hatóanyag-kombinációk alkalmazása glaukoma kezelésére szolgáló gyógyszerkészítmények előállítására
DE50114474D1 (de) Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen
ATE460175T1 (de) Stabile wässrige formulierung von interferon, präparationsmethode und dessen verwendung
CA2322878A1 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
DK0783307T3 (da) Anvendelse af 2,4-diaminopyrimidin-3-oxid eller et salt deraf til behandling af forstyrrelser i modning og strukturering af kollagen
WO2003007876A3 (en) N-fatty acid-amino acid conjugates and therapeutic uses
EP1072261A3 (en) Felbinac-containing patch
FR2751544A1 (fr) Composition therapeutique pour le traitement des verrues vulgaires
ATE241974T1 (de) Nimelulide enthaltendes pharmazeutisches präparat zur oralen verabreichung